Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. - Wikidata - wikimedia - TriplyDB

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

http://www.wikidata.org/entity/Q38806893

about

Case report: PET/CT, a cautionary tale Case report: malignant teratoma of the uterine corpus.The management of metastatic hepatic germ cell tumour in a young woman: case report and literature review.Advances in the management of testicular cancer.High-dose chemotherapy for male germ cell tumor.A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia.The role of high-dose chemotherapy in the treatment of testicular cancer.Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience.Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE).High dose chemotherapy including paclitaxel (T-ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. Preliminary report.Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study.A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study

P2860

Q33293417-4D3B67BE-1DA2-4D66-9FDB-CED7C5891408 Q33470744-46BCC8B6-E5EA-4D89-B4B2-21A0E6787F9E Q34524973-24695F6B-5A96-4DD2-8F86-4A9600AF507F Q35843721-0ABD4ED9-B237-49F5-A00A-F241042C4456 Q36563573-DDF2A61F-70C5-4F3B-ADE3-8EB2B0B7427E Q36610042-53D9B4D0-4B87-40F8-83AD-F85B0EFC3D47 Q38160470-00E7ECA0-19C6-4020-BA89-D5713F8E454B Q38666300-E41EA6A0-5150-46A3-9E12-3BEA16E376F6 Q46255293-E88D6AEA-FB5C-4A29-A2BF-3A61FCC67694 Q46614250-1DEEC1E5-4D8B-4F8D-B9C9-378A17540A98 Q46892343-1942D2F2-A204-4C35-AC94-648D18EED8C9 Q53164870-B3620F1F-B911-4F05-826D-DB07284F6A7F Q57579466-776B94CD-8243-4F76-B36A-505458E2ADEA

P2860

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

http://www.wikidata.org/entity/Q38806893

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Paclitaxel-containing high-dos ...... testicular germ cell tumours.

@en

type

label

Paclitaxel-containing high-dos ...... testicular germ cell tumours.

@en

prefLabel

Paclitaxel-containing high-dos ...... testicular germ cell tumours.

@en

P1433

Q38806893-D8C9870F-EF29-4E4B-89A0-629AF5114697

P1476

Q38806893-FDFF5BF6-4947-427F-A10E-03C36257A000

P2093

Q38806893-0D3959A5-AB81-47A9-839D-8AB56134B978

Q38806893-21F830B5-FDA0-464C-A645-6B9D2579FF16

Q38806893-28473E3D-8DEB-42BE-91C4-A8868A89887E

Q38806893-2B7A1CF6-4929-4DC7-923F-7D0B397003FD

Q38806893-6E375E8D-348D-4EE1-8735-C4B00107B9C6

Q38806893-A4319B3B-D530-4448-86DE-C8A2BEFB79AF

Q38806893-C46D3617-A792-4FA0-A30E-C588C7991E2F

Q38806893-D3333E3C-753C-4B9D-AD47-F5A050709E3F

P2860

Q38806893-02289D28-0736-4A0F-BE11-B455A0CC8214

Q38806893-0C860ABC-E724-4436-978B-4DC968F81CCF

Q38806893-1C56EC1D-88CF-4204-A47E-52DFB0F22278

Q38806893-200F9E54-18BC-45C3-B043-EFDE3C240CC9

Q38806893-2585F454-5104-4F02-A764-7C534812C9D4

Q38806893-29EB2FCE-D59A-4FAD-8C92-C672D3643434

Q38806893-437F8E3B-DFF1-43CB-A735-2B384AF5CAFD

Q38806893-47BBE759-6542-4C33-9B28-42D344287506

Q38806893-69A63286-C0CA-4526-B1A5-74CCA13D6951

Q38806893-7EBE9CE3-4795-4DE1-821B-A2E2A401BA4B

P2888

Q38806893-7675AD35-FE63-43C4-BB8C-6DA08C4C5688

P304

Q38806893-A3100D29-4BC4-4403-82B1-1633A9ABA9EE

P31

Q38806893-257B1F5C-AB2F-4559-AED0-EBBBFFB5C87E

P356

Q38806893-6D7F5B94-1261-4DAB-BDDF-461F6BB9ABE0

P407

Q38806893-A45E1C78-0FC3-4D79-A1FC-0DD061E288F9

P433

Q38806893-7317B466-F158-470A-9015-504F5530AF42

P478

Q38806893-4C84A87B-9517-47B6-BB57-AEDBC8DA52DB

P50

Q38806893-9F981C77-CFE1-4A87-ADE4-06CB78AE9544

P577

Q38806893-770C59AA-CC2C-4BEB-8136-ECA1368442C5

P5875

Q38806893-84B20439-3C53-478C-85AA-D426DE4D0735

P6179

Q38806893-D7240062-8512-4E21-8297-1DEDD7B60AC9

P698

Q38806893-E1845592-6680-4765-BC6D-7F44B10DAD86

P921

Q38806893-22F96AD4-CD48-498B-A76C-38ADCEDFA74E

P932

Q38806893-9AC4F380-182C-48AB-AC14-22DAC934522E

P356

P1433

British Journal of Cancer

P1476

Paclitaxel-containing high-dos ...... y testicular germ cell tumours

@en

P2093

C Giles

http://www.w3.org/2001/XMLSchema#string

D Driver

http://www.w3.org/2001/XMLSchema#string

E J Kanfer

http://www.w3.org/2001/XMLSchema#string

E S Newlands

http://www.w3.org/2001/XMLSchema#string

G J S Rustin

http://www.w3.org/2001/XMLSchema#string

M J Seckl

http://www.w3.org/2001/XMLSchema#string

R Haynes

http://www.w3.org/2001/XMLSchema#string

S J Harland

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere)

Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.

Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma.

High dose chemotherapy--results of American studies.

High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels.

Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.

Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.

P2888

P304

1169-1175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601664

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8673979

http://www.w3.org/2001/XMLSchema#string

P6179

1037717457

http://www.w3.org/2001/XMLSchema#string

P698

15026797

http://www.w3.org/2001/XMLSchema#string

P921

P932

2410221

http://www.w3.org/2001/XMLSchema#string